RAINBOW vs SHALBY: Stock Comparison

RAINBOW CHILDRENS MED vs SHALBYUpdated 18 Sept 26, 4:08 PM ISTNSE & company filings

RAINBOW CHILDRENS MED is the larger company by market capitalisation. RAINBOW CHILDRENS MED shows a higher ROE, a higher dividend yield and faster revenue growth, while SHALBY shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

RAINBOW leads 10; SHALBY leads 3 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

RAINBOWSHALBY

Valuation lens

What price are you paying?

Market CapContext only
₹14,702 Cr
₹1,491 Cr
P/E RatioSHALBY has the lower reading
51.52x
37.09x
P/B RatioSHALBY has the lower reading
8.92x
1.45x
EPSRAINBOW has the higher reading
₹5.19
₹1
Book ValueContext only
₹163.8
₹93.11
Dividend YieldRAINBOW has the higher reading
0.24%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
RAINBOW is the larger company
₹14,702 Cr vs ₹1,491 Cr
P/E Ratio
SHALBY has a lower P/E
37.09x vs 51.52x
P/B Ratio
SHALBY has a lower P/B
1.45x vs 8.92x
EPS
RAINBOW has higher earnings per share
₹5.19 vs ₹1
Dividend Yield
RAINBOW has a higher dividend yield
0.24% vs 0%
Revenue Growth (TTM YoY)
RAINBOW has faster revenue growth
24.3% vs 8.5%
EPS Growth (TTM YoY)
RAINBOW has faster EPS growth
39.1% vs 0%
Qtr Sales Growth
SHALBY has stronger quarterly sales growth
30.51% vs -12.65%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricRAINBOWSHALBY
SectorHealthcareHealthcare
IndustryHospitalHospital

Price

MetricRAINBOWSHALBY
Live Price₹1,454.7₹137.66
Day Change-1.27%-0.61%
Volume99,8051.5 L
52-Week High₹1,610₹274.7
52-Week Low₹1,084₹125.82
Distance from 52W High-9.65%-49.89%

Valuation

MetricRAINBOWSHALBY
Market Cap₹14,702 Cr₹1,491 Cr
P/E Ratio51.52x37.09x
P/B Ratio8.92x1.45x
EPS₹5.19₹1
Book Value₹163.8₹93.11
Dividend Yield0.24%0%

Growth

MetricRAINBOWSHALBY
Revenue Growth (TTM YoY)24.3%8.5%
EPS Growth (TTM YoY)39.1%0%
Qtr Sales Growth-12.65%30.51%
Qtr Profit Growth-15.72%-58.13%

Profitability & Leverage

MetricRAINBOWSHALBY
ROE14.8%9.05%
ROCE18.17%9.51%
Net Margin16.34%3.28%
Operating Margin26.24%14.3%
Debt to Equity0.01x0.1x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricRAINBOWSHALBY
Promoter Holding49.84%74.33%
FII Holding16.03% 1.21 pp4.46% 0.1 pp
DII Holding22.56% 1.43 pp0.3% 0.05 pp
Public Holding11.39% 0.28 pp20.26% 0.15 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: RAINBOW CHILDRENS MED and SHALBY.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.